J Cardiovasc Transl Res. 2014 Apr;7(3):310-20. doi: 10.1007/s12265-014-9540-1. Epub 2014 Feb 06.
Journal of cardiovascular translational research
Gaetano M De Ferrari
PMID: 24500409 DOI: 10.1007/s12265-014-9540-1
Heart failure (HF) is accompanied by an autonomic imbalance that is almost always characterized by both increased sympathetic activity and withdrawal of vagal activity. Experimentally, vagal stimulation has been shown to exert profound antiarrhythmic activity and to improve cardiac function and survival in HF models. A open-label pilot clinical study in 32 patients with chronic HF has shown safety and tolerability of chronic vagal stimulation associated with subjective (improved quality of life and 6-min walk test) and objective improvements (reduced left ventricular systolic volumes and improved left ventricular ejection fraction). Three larger clinical studies, including a phase III trial are currently ongoing and will evaluate the clinical role of this new approach.